[1] This selectivity, first documented by Raun and colleagues in the landmark 1998 paper that called ipamorelin "the first selective growth hormone secretagogue," remains its defining characteristic in the research literature
This is because prolonged use and inappropriately high doses can cause irritation, rebound hyperpigmentation and even ochronosis
The Wolverine protocol puts both systems to work at the same time
Additionally, the efficacy and safety of glutathione suppositories for specific disease states and interactions with other medications should be thoroughly evaluated by a healthcare professional
So, whats the hype all about
The options may be chosen on the product page View Details For GHRH + GHRP synergy Research For GHRH-mediated GH pulsatility Research For Alternative GHRH pairing Research For Tissue repair alongside GH therapy Research Description Ipamorelin is a pentapeptide growth hormone secretagogue with remarkable selectivity